NEW: Premarket Now Starts at 4AM!

We’re excited to announce the extension of premarket and aftermarket hours! Our members now have access to quotes daily from 4:00 AM to 8:00 PM ET — offering greater flexibility and deeper insights into market trends beyond regular trading hours.

Upgrade to FINVIZ*Elite to access premarket quotes »

ABBV

Abbvie Inc

Apr 25 • 04:00PM ET

186.06

Dollar change +5.69
Percentage change 3.15	%

Healthcare • Drug Manufacturers - General • USA • NYSE

Peers: JNJ PFE MRK LLY BMY GILD AMGN REGN VRTX BIIB

| Held by: VTI VOO SPY IVV VTV SCHD XLV VIG VYM VHT

Scroll to Statements

Index	S&P 500	P/E	79.15	EPS (ttm)	2.35	Insider Own	0.11%	Shs Outstand	1.77B	Perf Week	7.56%
Market Cap	329.14B	Forward P/E	13.32	EPS next Y	13.96	Insider Trans	-12.61%	Shs Float	1.77B	Perf Month	-7.57%
Income	4.17B	PEG	5.20	EPS next Q	3.14	Inst Own	73.45%	Short Float	0.95%	Perf Quarter	9.25%
Sales	57.37B	P/S	5.74	EPS this Y	20.54%	Inst Trans	0.43%	Short Ratio	2.26	Perf Half Y	-1.43%
Book/sh	1.88	P/B	98.78	EPS next Y	14.47%	ROA	3.14%	Short Interest	16.84M	Perf Year	9.74%
Cash/sh	3.14	P/C	59.25	EPS next 5Y	15.23%	ROE	61.94%	52W Range	153.58 - 218.66	Perf YTD	4.70%
Dividend Est.	6.51 (3.50%)	P/FCF	18.46	EPS past 5Y	-14.67%	ROI	6.47%	52W High	-14.91%	Beta	0.58
Dividend TTM	6.38 (3.43%)	Quick Ratio	0.55	Sales past 5Y	12.19%	Gross Margin	84.97%	52W Low	21.15%	ATR (14)	6.94
Dividend Ex-Date	Apr 15, 2025	Current Ratio	0.66	EPS Y/Y TTM	-12.14%	Oper. Margin	30.71%	RSI (14)	49.30	Volatility	3.11% 4.28%
Employees	55000	Debt/Eq	20.40	Sales Y/Y TTM	5.45%	Profit Margin	7.26%	Recom	1.86	Target Price	215.22
Option/Short	Yes / Yes	LT Debt/Eq	18.36	EPS Q/Q	-5.32%	Payout	263.15%	Rel Volume	1.41	Prev Close	180.37
Sales Surprise	3.22%	EPS Surprise	3.39%	Sales Q/Q	8.39%	Earnings	Apr 25 BMO	Avg Volume	7.45M	Price	186.06
SMA20	0.73%	SMA50	-6.04%	SMA200	-1.17%	Trades		Volume	10,477,886	Change	3.15%

Date	Action	Analyst	Rating Change	Price Target Change
Apr-22-25	Initiated	Cantor Fitzgerald	Overweight	$210
Dec-10-24	Resumed	BofA Securities	Neutral	$191
Dec-05-24	Downgrade	Daiwa Securities	Outperform → Neutral	$180
Nov-22-24	Upgrade	Leerink Partners	Market Perform → Outperform	$206
Nov-15-24	Initiated	Wolfe Research	Outperform	$205
Nov-04-24	Upgrade	Argus	Hold → Buy
Oct-17-24	Initiated	Bernstein	Mkt Perform	$203
Jun-05-24	Upgrade	HSBC Securities	Hold → Buy	$185
May-17-24	Initiated	Cantor Fitzgerald	Overweight	$200
Jan-29-24	Upgrade	William Blair	Mkt Perform → Outperform
Dec-18-23	Downgrade	HSBC Securities	Buy → Hold
Dec-11-23	Upgrade	Goldman	Neutral → Buy
Nov-09-23	Initiated	Deutsche Bank	Hold	$150
Oct-30-23	Upgrade	Barclays	Equal Weight → Overweight	$160 → $170
Oct-20-23	Resumed	UBS	Neutral	$157 → $150
Sep-29-23	Initiated	Raymond James	Outperform	$177
Jul-25-23	Initiated	William Blair	Mkt Perform
Jul-14-23	Initiated	HSBC Securities	Buy	$167
Apr-05-23	Downgrade	Argus	Buy → Hold
Mar-01-23	Initiated	Guggenheim	Buy	$172

Show Previous Ratings

Apr-26-25 06:05PM	4 Surefire Dividend Stocks to Buy in the Stock Market Sell-Off (Motley Fool)
12:20PM	China weighs U.S. tariff exemptions, Alphabet reports Q1 beat: Morning Buzz (TipRanks)
03:04AM	AbbVie Inc (ABBV) Q1 2025 Earnings Call Highlights: Strong Growth in Immunology and ... (GuruFocus.com)
01:11AM	Q1 2025 AbbVie Inc Earnings Call (Thomson Reuters StreetEvents)
Apr-25-25 10:07PM	How Much Would It Take To Earn $100 A Month From AbbVie Stock (Benzinga)
09:45PM	Loading…
09:45PM	Morningstar \| A Weekly Summary of Stock Ideas and Developments in the Companies We Cover (Morningstar Research)
05:17PM	Why AbbVie Stock Topped the Market Today (Motley Fool)
05:17PM	AbbVie's First Quarter Beat And Raise Leaves Room For More (Seeking Alpha)
04:38PM	Is AbbVie Inc. (ABBV) the Best Dividend Stock to Buy for Long-Term Passive Income? (Insider Monkey)
04:05PM	AbbVie Hikes Its Outlook On The Back Of Two Powerhouse Drugs (Investor's Business Daily)
04:00PM	AbbVie: Q1 Earnings Reinforce Positive Momentum (Seeking Alpha)
02:00PM	AbbVie Q1 Earnings Review: Typically Strong Performance, Aesthetics Aside (Seeking Alpha)
01:18PM	AbbVie Beats on Q1 Earnings & Sales, Raises '25 EPS View (Zacks)
01:11PM	Bitcoin extends rally, AbbVie earnings beat, Phillips 66 miss (Yahoo Finance Video)
12:49PM	AbbVie Stock Rises on Stronger-Than-Expected Results, Profit Outlook Lift (Investopedia)
12:15PM	Loading…
12:15PM	Analyst Report: AbbVie Inc. (Morningstar Research)
12:14PM	AbbVie Inc. (ABBV) Q1 2025 Earnings Call Transcript (Seeking Alpha)
12:03PM	AbbVie Stock Rises Despite Risks as Earnings Beat Forecasts (Barrons.com)
12:02PM	Drugmaker Abbvie Ramps Up Domestic Manufacturing Plans on Tariff Threats (The Wall Street Journal)
11:33AM	AbbVie warns of tariff exposure, U.S. policy risks while boosting forecast (Investing.com)
11:08AM	Earnings Data Deluge (Zacks)
10:35AM	Conflicting Claims on U.S./China Trade Sends Pre-Markets in the Red (Zacks)
10:00AM	AbbVie Stock Rises as Earnings Beat, Guidance Raised. But Tariffs Could Bite Yet. (Barrons.com)
09:53AM	AbbVie, Schlumberger, Colgate-Palmolive: Trending tickers (Yahoo Finance Video)
09:44AM	Stocks to Watch on Friday: Alphabet, AbbVie, T-Mobile, Skechers (The Wall Street Journal)
09:30AM	AbbVie (ABBV) Reports Q1 Earnings: What Key Metrics Have to Say (Zacks)
09:20AM	If You Wanted To Buy AbbVie and Didn't, There's Still Time To Buy (MarketBeat)
09:15AM	Biogen: Is This A Value Trap, Or Is The Great Turnaround Imminent? (Seeking Alpha)
08:55AM	AbbVie (ABBV) Q1 Earnings and Revenues Beat Estimates (Zacks)
08:50AM	AbbVie Jumps After Hiking Its Outlook On The Back Of Strong Immunology Sales (Investor's Business Daily)
08:24AM	Loading…
08:24AM	AbbVie Stock Jumps as Earnings Beat, Guidance Raised. But Tariffs Could Bite Yet. (Barrons.com)
08:21AM	AbbVie Inc. (ABBV): One of the Growing Dividend Stocks with Low PE Ratios (Insider Monkey)
08:19AM	AbbVie (NYSE:ABBV) Reports Bullish Q1 (StockStory)
07:52AM	AbbVie: Q1 Earnings Snapshot (Associated Press Finance)
07:47AM	AbbVie lifts profit forecast on strong sales of newer immunology drugs (Reuters)
07:43AM	AbbVie Reports First-Quarter 2025 Financial Results (PR Newswire)
Apr-24-25 07:00PM	Colgate-Palmolive earnings, consumer sentiment: What to Watch (Yahoo Finance Video)
08:30AM	AbbVie Submits Biologics License Application to U.S. FDA for TrenibotulinumtoxinE (TrenibotE) for the Treatment of Glabellar Lines (PR Newswire)
07:40AM	Merck (MRK) Q1 Earnings and Revenues Top Estimates (Zacks)
03:01AM	AbbVie (ABBV) Reports Earnings Tomorrow: What To Expect (StockStory)
Apr-23-25 07:08PM	Buy Stock in These Healthcare Leaders as Q1 Earnings Approach? ABBV, HCA (Zacks)
10:20AM	Why AbbVie Inc. (ABBV) is Among the Best Stocks That Will Always Grow (Insider Monkey)
09:25AM	The Zacks Analyst Blog Highlights Gilead Sciences, Bristol Myers, Merck, AbbVie and Sanofi (Zacks)
08:34AM	Buy, Sell or Hold ABBV Stock? Key Tips Ahead of Q1 Earnings (Zacks)
08:30AM	2 High-Yield Dividend Stocks to Buy for Passive Income (Motley Fool)
Apr-22-25 02:28PM	Final Trades: 3M, Abbvie, Salesforce and Intuitive Surgical (CNBC TV)
11:13AM	Eli Lilly, Vertex, AbbVie, and More Pharma Stocks to Own as Tariffs Loom (Barrons.com)
10:00AM	Analysts Estimate Pfizer (PFE) to Report a Decline in Earnings: What to Look Out for (Zacks)
09:48AM	Cantor initiates coverage of U.S. large-cap pharma stocks: Gilead, AbbVie at Buy (Investing.com)
09:15AM	Seeking Clues to AbbVie (ABBV) Q1 Earnings? A Peek Into Wall Street Projections for Key Metrics (Zacks)
09:06AM	Will These 5 Large Drug Maker Stocks Surpass Q1 Earnings Forecast? (Zacks)
08:30AM	Do Options Traders Know Something About AbbVie (ABBV) Stock We Don't? (Zacks)
Apr-21-25 05:45PM	AbbVie (ABBV) Stock Moves -1.64%: What You Should Know (Zacks)
10:15AM	Jim Cramer Is Bullish on AbbVie Inc. (ABBV) Ahead of Earnings (Insider Monkey)
Apr-20-25 08:15AM	Is AbbVie Stock a Buy? (Motley Fool)
05:52AM	Wall Street Week Ahead (Seeking Alpha)
05:00AM	What To Expect in the Markets This Week (Investopedia)
Apr-19-25 11:13AM	Is AbbVie Inc. (ABBV) the Best Pharma Stock to Buy for Long Term Growth? (Insider Monkey)
11:00AM	Tesla, Google To Report Earnings As Investors Watch Out For Consumer Confidence, Jobless Claims (Seeking Alpha)
11:00AM	Tesla, Amazon To Report Earnings As Investors Watch Out For Consumer Confidence, Jobless Claims (Seeking Alpha)
11:00AM	Tesla, Alphabet To Report Earnings As Investors Watch Out For Consumer Confidence, Jobless Claims (Seeking Alpha)
Apr-18-25 01:02PM	Cerevel Therapeutics Holdings, Inc. Sued for Securities Law Violations Investors Should Contact Levi & Korsinsky Before June 3, 2025 to Discuss Your Rights ABBV (GlobeNewswire)
10:02AM	Is AbbVie Inc. (ABBV) the Best Large-Cap Value Stock to Buy as the Recession Hits? (Insider Monkey)
10:00AM	AbbVie (ABBV) Earnings Expected to Grow: What to Know Ahead of Next Week's Release (Zacks)
Apr-17-25 09:50AM	AbbVie Inc. (ABBV): Among the Innovative Healthcare Stocks to Watch in 2025 (Insider Monkey)
08:10AM	My Dividend Stock Portfolio: New All-Time Dividend Record In March - 100 Holdings With 15 Buys (Seeking Alpha)
Apr-16-25 05:51PM	Neurocrine Biosciences: Recent Selloff Has Created A Potential Buying Opportunity (Seeking Alpha)
04:29PM	Analyst Report: AbbVie Inc. (Morningstar Research)
02:41PM	IYH: Healthcare Dashboard For April (Seeking Alpha)
11:20AM	AbbVie Inc. (ABBV): One of the Best Dividend Monarchs to Invest in Now (Insider Monkey)
09:45AM	Top Cancer Stocks to Buy to Boost Your Portfolio's Health (Zacks)
05:06AM	Unpacking Q4 Earnings: AbbVie (NYSE:ABBV) In The Context Of Other Therapeutics Stocks (StockStory)
04:33AM	The Zacks Analyst Blog AbbVie, The TJX, The Charles Schwab, Enzo Biochem and CVD Equipment (Zacks)
Apr-15-25 04:30PM	Top Research Reports for AbbVie, TJX & Charles Schwab (Zacks)
10:43AM	Johnson & Johnson: First Look At Q1 Earnings - Solid Quarter Will Calm Nerves (Seeking Alpha)
07:45AM	AbbVie Inc. (ABBV): One of the High Growth Forever Dividend Stocks to Invest In (Insider Monkey)
06:54AM	The Zacks Analyst Blog Merck and AbbVie (Zacks)
06:20AM	Is Invesco Large Cap Value ETF (PWV) a Strong ETF Right Now? (Zacks)
Apr-14-25 10:37AM	ABBV vs. MRK: Which Drug Giant is a Better Buy Now? (Zacks)
02:17AM	The Zacks Analyst Blog AbbVie's, Rinvoq and AstraZeneca's and Novartis (Zacks)
Apr-13-25 05:39PM	Is AbbVie Inc. (ABBV) the Best Stock for 15 Years? (Insider Monkey)
01:15PM	ClearBridge Appreciation ESG Strategy Q1 2025 Commentary (Seeking Alpha)
09:15AM	SCHD's Portfolio Shake-Up: What It Means For Investors (Rating Downgrade) (Seeking Alpha)
Apr-12-25 11:00AM	Goldman Sachs, J&J, To Report Earnings As Investors Watch Out For Retail Sales Data (Seeking Alpha)
01:27AM	Dividend Champion, Contender, And Challenger Highlights: Week Of April 13 (Seeking Alpha)
Apr-11-25 02:33PM	Final Trades: TJX, Meta, Abbvie and Taiwan Semi (CNBC TV)
12:45PM	IGD: Capital Erosion And Shrinking Dividend Payouts (Seeking Alpha)
11:47AM	Pharma Stock Roundup: EU Nod to Expanded Use of ABBV, AZN Drugs & More (Zacks)
10:16AM	Here's Why Clearbridge Growth Strategy Sold AbbVie (ABBV) (Insider Monkey)
06:20AM	Is SPDR Portfolio S&P 500 High Dividend ETF (SPYD) a Strong ETF Right Now? (Zacks)
Apr-10-25 12:58PM	S&P, Dow Jones Pharma Names Rattled Again On Trump's Tariffs Whiplash (Investor's Business Daily)
09:44AM	Pfizer Stock Falls to New 52-Week Low: Should You Buy the Dip? (Zacks)
09:00AM	Investors Heavily Search AbbVie Inc. (ABBV): Here is What You Need to Know (Zacks)
09:00AM	New York Plastic Surgical Group and Deep Blue Med Spa Receive State and National Recognition by Allergan Aesthetics (GlobeNewswire)
08:54AM	Pharma Stocks Rebound as Trump Announces a 90-Day Pause on Tariffs (Zacks)
08:19AM	ClearBridge Growth Strategy Q1 2025 Commentary (Seeking Alpha)
07:00AM	3 Biopharmaceutical Stocks Bucking the Sell-Off (MarketBeat)
Apr-09-25 06:33PM	Analyst Report: AbbVie Inc. (Morningstar Research)
05:29PM	AbbVie: Thriving Beyond Humira's Patent Cliff (Upgrade) (Seeking Alpha)
10:06AM	Dow Jones, S&P 500 Pharma Names Recover After Trump Backs Off His Tariffs Plan (Investor's Business Daily)

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, including blood cancers, virology, hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders, such as Parkinson's, metabolic, comprising thyroid disease and complications associated with cystic fibrosis, pain associated with endometriosis, and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Stewart Jeffrey Ryan	EVP, CHIEF COMMERCIAL OFFICER	Mar 31 '25	Option Exercise	79.02	25,700	2,030,814	112,066	Apr 02 05:00 PM
Stewart Jeffrey Ryan	EVP, CHIEF COMMERCIAL OFFICER	Mar 31 '25	Sale	210.08	58,832	12,359,504	53,234	Apr 02 05:00 PM
Stewart Jeffrey Ryan	Officer	Mar 31 '25	Proposed Sale	210.09	58,832	12,359,897		Mar 31 05:30 PM
Reents Scott T	EVP, CHIEF FINANCIAL OFFICER	Mar 14 '25	Sale	212.34	17,644	3,746,527	11,577	Mar 18 05:00 PM
Reents Scott T	Officer	Mar 14 '25	Proposed Sale	212.35	17,644	3,746,628		Mar 14 04:34 PM
GONZALEZ RICHARD A	Director	Feb 28 '25	Sale	205.11	92,460	18,964,471	395,097	Mar 04 05:00 PM
GONZALEZ RICHARD A	Director	Mar 03 '25	Sale	210.53	6,168	1,298,549	388,929	Mar 04 05:00 PM
Siatis Perry C	EVP, GC AND SECRETARY	Mar 03 '25	Option Exercise	159.88	18,008	2,879,040	22,627	Mar 04 05:00 PM
Siatis Perry C	EVP, GC AND SECRETARY	Mar 03 '25	Sale	210.00	18,008	3,781,680	4,619	Mar 04 05:00 PM
Siatis Perry C	EVP, GC AND SECRETARY	Feb 28 '25	Sale	206.30	9,892	2,040,722	4,619	Mar 04 05:00 PM
RICHMOND TIMOTHY J.	EVP, CHIEF HR OFFICER	Mar 03 '25	Sale	210.45	21,250	4,472,039	6,130	Mar 04 05:00 PM
GONZALEZ RICHARD A	Officer	Mar 03 '25	Proposed Sale	210.53	6,168	1,298,550		Mar 03 05:57 PM
PERRY C SIATIS	Officer	Mar 03 '25	Proposed Sale	210.00	18,008	3,781,680		Mar 03 04:28 PM
TIMOTHY RICHMOND	Officer	Mar 03 '25	Proposed Sale	210.46	21,250	4,472,184		Mar 03 04:08 PM
GONZALEZ RICHARD A	Officer	Feb 28 '25	Proposed Sale	205.11	92,460	18,964,882		Feb 28 05:37 PM
Buckbee Kevin K	SVP, CONTROLLER	Feb 26 '25	Option Exercise	98.48	16,260	1,601,313	28,906	Feb 28 05:00 PM
Buckbee Kevin K	SVP, CONTROLLER	Feb 26 '25	Sale	203.41	18,944	3,853,372	11,496	Feb 28 05:00 PM
RICHMOND TIMOTHY J.	EVP, CHIEF HR OFFICER	Feb 26 '25	Option Exercise	114.36	22,210	2,539,936	66,494	Feb 28 05:00 PM
RICHMOND TIMOTHY J.	EVP, CHIEF HR OFFICER	Feb 26 '25	Sale	202.90	29,917	6,070,036	44,284	Feb 28 05:00 PM
PERRY C SIATIS	Officer	Feb 28 '25	Proposed Sale	206.31	9,892	2,040,790		Feb 28 04:12 PM
Buckbee Kevin K	Officer	Feb 26 '25	Proposed Sale	203.41	18,944	3,853,398		Feb 26 05:47 PM
TIMOTHY RICHMOND	Officer	Feb 26 '25	Proposed Sale	202.90	29,917	6,070,176		Feb 26 04:04 PM
Siatis Perry C	EVP, GC AND SECRETARY	Feb 20 '25	Sale	197.90	5,778	1,143,453	22,381	Feb 24 05:00 PM
PERRY C SIATIS	Officer	Feb 20 '25	Proposed Sale	197.90	5,778	1,143,492		Feb 20 04:10 PM
Buckbee Kevin K	SVP, CONTROLLER	Dec 16 '24	Option Exercise	93.50	1,800	168,300	8,783	Dec 18 05:00 PM
Buckbee Kevin K	SVP, CONTROLLER	Dec 16 '24	Sale	172.24	1,800	310,032	6,983	Dec 18 05:00 PM
Buckbee Kevin K	Officer	Dec 16 '24	Proposed Sale	172.25	1,800	310,045		Dec 16 05:34 PM
Hudson Thomas J	Officer	Aug 08 '24	Proposed Sale	189.08	49,170	9,297,210		Aug 08 05:40 PM
GONZALEZ RICHARD A	EXECUTIVE CHAIRMAN OF BOARD	Aug 05 '24	Sale	186.52	66,500	12,403,580	446,599	Aug 07 05:00 PM
Hudson Thomas J	Officer	Aug 07 '24	Proposed Sale	187.62	101,886	19,115,380		Aug 07 04:22 PM
GONZALEZ RICHARD A	Officer	Aug 05 '24	Proposed Sale	187.36	66,500	12,459,360		Aug 05 10:54 AM
GONZALEZ RICHARD A	EXECUTIVE CHAIRMAN OF BOARD	Jul 17 '24	Option Exercise	77.49	282,845	21,919,048	795,944	Jul 19 04:40 PM
GONZALEZ RICHARD A	EXECUTIVE CHAIRMAN OF BOARD	Jul 17 '24	Sale	175.00	282,845	49,497,875	513,099	Jul 19 04:40 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

ABBV

Abbvie Inc

Upgrade your FINVIZ experience